CDC Logo Skip Top Nav
 CDC Home PageSearch the CDCHealth Topics A though Z
Skip
Division of Tuberculosis Elimination
About DTBE Upcoming Events Site Map CDC en Espanol Contact Us
 
Skip the Contents menu

Contents

Skip the Resources menu

Resources



U.S. Department of Health and Human Services
 
 

Guide to the Application of Genotyping to Tuberculosis Prevention and Control

Return to Genotyping Main Menu

Tuberculosis Genotyping Case Studies: How TB Programs Have Used Genotyping

Identification of Nontraditional Transmission Settings

The Maryland Department of Health and Mental Hygiene described how universal genotyping can strengthen traditional TB control efforts. Maryland genotyped all of its M. tuberculosis isolates received during 1996 to 2000 and recently published the results (Cronin 2002).

Of 1,172 patients with genotyping results, genotypes from 436 matched those of at least one other patient in the state. Of the 436 clustered patients, 115 were thought to have acquired TB recently, and in 114 a setting of presumed transmission could be identified. Before the genotyping results were known, routine contact investigations identified epidemiologic links for 72 of the 114 patients (Table 2.3). During follow-up cluster investigations, additional information resulted in the identification of 42 patients with additional epidemiologic links.

Maryland’s cluster investigations, which were conducted after the genotyping results were available, helped to identify 30% more epidemiologic links than the original contact investigations. Many of these newly discovered epidemiologic links suggested that TB transmission occurred in settings that are often not asked about in routine contact investigations (e.g., homeless shelters, bars, churches, and nursing homes). The new information led TB program staff to screen previously unsuspected groups of persons.


Table 2.3. Transmission settings or relationships identified by either routine contact investigations or by cluster investigations for 114 patients with recently acquired tuberculosis — Maryland, 1996--2000.

Traditional

Transmission setting or relationship Total patients with known setting Setting identified by routine contact investigation (%) Setting identified only by cluster investigation (%)
Household
28
25 ( 89)
3 ( 11)
Close relative
13
13 (100)
0
Close friend
17
11 ( 65)
6 ( 35)
Total traditional
58
49 ( 84)
9 ( 16)

Nontraditional*

Transmission setting or relationship Total patients with known setting Setting identified by routine contact investigation (%) Setting identified only by cluster investigation (%)
Hospital
10
5 ( 50)
5 ( 50)
Other workplace
6
6 (100)
0
Social club
11
7 ( 64)
4 ( 36)
Homeless shelter
5
0
5 (100)
Bar
10
1 ( 10)
9 ( 90)
Prison or jail
5
3 ( 60)
2 ( 40)
Store
2
0
2 (100)
Church
2
0
2 (100)
Nursing home
2
0
2 (100)
School
1
0
1 (100)
Ship
1
1 (100)
0
Mortuary
1
0
1 (100)
Total nontraditional
56
23 ( 41)
33 ( 59)

* The definition of nontraditional settings of transmission used by Maryland is not identical to the one used in Table 4.2.

Last Reviewed: 05/18/2008
Content Source: Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

 

 
Back to Top of Page


If you would like to order any of the DTBE publications please visit the online order form.

You will need Adobe Acrobat™ Reader v5.0 or higher to read pages that are in PDF format.  Download the Adobe Acrobat™ Reader.

If you have difficulty accessing any material on the DTBE Web site because of a disability, please contact us in writing or via telephone and we will work with you to make the information available.

Division of Tuberculosis Elimination
Attn: Content Manager, DTBE Web site
Centers for Disease Control and Prevention
1600 Clifton Rd., NE Mailstop E-10
Atlanta, GA 30333
CDC-INFO at (1-800) 232-4636
TTY: 1 (888) 232-6348
E-mail: cdcinfo@cdc.gov


Skip Bottom Nav Home | Site Map | Contact Us
Accessibility | Privacy Policy Notice | FOIA | USA.gov
CDC Home | Search | Health Topics A-Z

Centers for Disease Control & Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Please send comments/suggestions/requests to: CDCINFO@cdc.gov